| Brooke Adams Vacovsky, MSN, RN, AGCNS-BC | |
|
2401 W Belvedere Ave, Baltimore, MD 21215-5270 | |
| (410) 601-8133 | |
| Not Available |
| Full Name | Brooke Adams Vacovsky |
|---|---|
| Gender | Female |
| Speciality | Clinical Nurse Specialist - Acute Care |
| Location | 2401 W Belvedere Ave, Baltimore, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013592690 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SA2100X | Clinical Nurse Specialist - Acute Care | CS000158 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Brooke Adams Vacovsky, MSN, RN, AGCNS-BC 1947 Laurel Oak Dr, Bel Air, MD 21015-1932 Ph: (410) 790-1063 | Brooke Adams Vacovsky, MSN, RN, AGCNS-BC 2401 W Belvedere Ave, Baltimore, MD 21215-5270 Ph: (410) 601-8133 |
News Archive
By using mice lacking a crucial gene that controls the process of chromatin remodeling of cytokines including those responsible for inflammation and comparing them to normal wild type mice with the gene, researchers at the George Washington University School of Medicine and Health Sciences have shown that the gene, Mta1, is essential for the parasite Schistosoma haematobium to establish a productive infection and survival in the host.
According to new research number blindness is more common than word blindness.
Gastrointestinal stroma tumors (GIST) are cancers that start in specialized nerve cells found in the digestive system, from the esophagus and stomach to the intestines and rectum.
Generex Biotechnology Corporation, the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced that it has achieved enrolled of over 400 subjects in its pivotal global Phase III study of its flagship product, Generex Oral-lyn™, a proprietary buccal insulin spray product designed to replace prandial injections of insulin.
Halozyme Therapeutics, Inc. today announced insulin variability study results that demonstrated reduced intrasubject absorption variability for the combination of lispro, a meal time analog insulin, plus PH20 (hyaluronidase) compared to subcutaneous injection of lispro alone.
› Verified 2 days ago
Jennifer Helzer, APRN-CNS Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 22 S Greene St, Baltimore, MD 21201 Phone: 410-350-7234 | |
Stephanie Morgenstern, APRN, ACCNS-P Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 1800 Orleans St, Baltimore, MD 21287 Phone: 339-235-0624 | |
Megan Wanzer, DNP, CRNP, CNS, CCRN Clinical Nurse Specialist Medicare: Medicare Enrolled Practice Location: 22 S Greene St, Baltimore, MD 21201 Phone: 410-328-5382 | |
Mr. Timothy Henrique Anthony Madeira, CRNP, APRN-CNS Clinical Nurse Specialist Medicare: Medicare Enrolled Practice Location: 600 N Wolfe St, Baltimore, MD 21287 Phone: 410-955-5080 | |
Elizabeth K Zink, MS, RN, CCNS, CNRN Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 1800 Orleans St Rm 3074, Baltimore, MD 21287 Phone: 410-955-5253 | |
Kenneth G Muthee, Clinical Nurse Specialist Medicare: Medicare Enrolled Practice Location: 1340 Smith Ave Ste 200, Baltimore, MD 21209 Phone: 443-500-9251 Fax: 410-779-1314 |